To understand the effects of BRAF/MAPK inhibition specifically in tumor cells, we characterized gene expression changes after treatment in the tumor epithelial compartment to identify potential tumor cell-intrinsic mechanisms underlying patient response. The gene discussed is BRAF; the disease is neoplasm.